Patent ID: 9259503
Filing Date: 2016-02-16
CPC Classification: A61B,A61F,A61K,A61L,A61P,C12Y

Claim Text:
1. A method for treating wounded internal tissue in a mammal comprising applying to wounded internal tissue for a time sufficient to join or approximate said wounded tissue and/or to reduce the flow of fluid from said wounded tissue at least one haemostatically effective amount of a casted haemostatic material, wherein said casted haemostatic material consists essentially of a substantially homogenous mixture of a fibrinogen component and a fibrinogen activator, wherein said fibrinogen component is present in an amount between 26 to about 450 mg per square centimeter of the surface intended to contact the wounded internal tissue being treated and wherein the fibrinogen activator is employed between about 0.0087-1.000 mg fibrinogen component, and wherein said fibrinogen component and fibrinogen activator are cooled to about 4° C.+/−2° C. before casting.